Floatz logo

TIPIRACIL

Stage IVA Colon Cancer AJCC v8

Academic and Community Cancer Research UnitedSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Stage IVA Colon Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
Assaf-Harofeh Medical Center
Phase 4BB
Eloxatin
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2BB
FLUOROURACILUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2BB
Irinotecan
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2B
Regorafenib
City of Hope Medical Center
Phase 2B

View all 34 →

Same molecule, other indications

TIPIRACIL is also rated in:

colorectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
69 / 100
View asset →
rectal cancerDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →